---
layout: splash
title: 코미팜 (041960)
excerpt: 코미팜의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 코미팜, 041960
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 4,060 | <span style="color: cornflowerblue">-1.3<small>%</small></span> | Q:제약 | - | 5.1 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 동물약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2001년 10월 30일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 양경훈, 문성철(각자 대표이사) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.komipharm.com](http://www.komipharm.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 05&#x2011;29 | | [주요사항보고서(자기주식취득결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240529000068){:target="_blank"} |
| 05&#x2011;28 | | [자기주식취득결과보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240528000495){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![041960](/stock/images/041960.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 4,060 | <span style="color: cornflowerblue">-1.3<small>%</small></span> | <span style="color: cornflowerblue">-2.2<small>%</small></span> | <span style="color: cornflowerblue">-3.8<small>%</small></span> | <span style="color: cornflowerblue">-5.4<small>%</small></span> | <span style="color: cornflowerblue">-3.3<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-42.8<small>%</small></span> | 33.1<small>%</small> | -1.29 | -45.9<small>%</small> | -31.0<small>%</small> | 0.9 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | - | 5.1 | - | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/041960/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=041960){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A041960&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=041960){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/041960){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/041960/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![041960](/stock/images/041960_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -42.8<small>%</small> | 33.1<small>%</small> | -1.29 | -45.9<small>%</small> | -31.0<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -16.1<small>%</small> | 32.8<small>%</small> | -0.49 | -30.3<small>%</small> | -13.4<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -35.4<small>%</small> | 27.8<small>%</small> | -1.28 | -43.8<small>%</small> | -28.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -11.7<small>%</small> | 21.8<small>%</small> | -0.54 | -17.3<small>%</small> | -9.8<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -25.8<small>%</small> | 20.3<small>%</small> | -1.27 | -26.3<small>%</small> | -14.0<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -18.2<small>%</small> | 16.2<small>%</small> | -1.12 | -19.3<small>%</small> | -10.8<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -22.0<small>%</small> | 8.8<small>%</small> | -2.51 | -23.1<small>%</small> | -11.8<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -9.2<small>%</small> | 5.8<small>%</small> | -1.59 | -10.5<small>%</small> | -10.2<small>%</small> |
| MACD[^fn_tech_metric_macd] | -20.7<small>%</small> | 24.8<small>%</small> | -0.83 | -22.2<small>%</small> | -14.4<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![041960](/stock/images/041960_corr.png){: .align-center}

|       | [리튬포어스](/073570/) | [F&F](/383220/) | [이오플로우](/294090/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [와이지엔터테인먼트](/122870/) | [JYP Ent.](/035900/) | [하이드로리튬](/101670/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![041960](/stock/images/041960_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}